Menu Search
Equities

Medicure Inc

NGQ1:MUN

Medicure Inc

Actions
  • Price (EUR)0.665
  • Today's Change0.00 / 0.00%
  • Shares traded6.00k
  • 1 Year change-34.80%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Medicure Inc's revenues fell -5.94%from 23.07m to 21.69m. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a reduction in net income from a gain of 1.37m to a loss of 922.00k.
Gross margin61.41%
Net profit margin-12.56%
Operating margin-12.35%
Return on assets-9.16%
Return on equity-12.90%
Return on investment-12.73%
More ▼

Cash flow in CADView more

In 2023, Medicure Inc increased its cash reserves by 31.13%, or 1.51m. The company earned 2.08m from its operations for a Cash Flow Margin of 9.58%. In addition the company used 270.00k on investing activities and also paid 297.00k in financing cash flows.
Cash flow per share-0.0412
Price/Cash flow per share--
Book value per share1.87
Tangible book value per share0.7466
More ▼

Balance sheet in CADView more

Medicure Inc uses little debt in its capital structure as supported by a debt to capital ratio of 2.02%.
Current ratio1.87
Quick ratio1.42
Total debt/total equity0.0206
Total debt/total capital0.0202
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.